GenScript Bio (01548): CARVYKTI's fourth quarter trade sales revenue is approximately 334 million US dollars.
Kingsley Biotechnology (01548) released an announcement regarding the collaboration between Legend Biotech and Janssen Biotech...
GENSCRIPT BIO (01548) announced that, based on the cooperation and licensing agreement entered into by Legend Biotech and Janssen Biotech, Inc. (Johnson & Johnson) on December 21, 2017, CARVYKTI is expected to generate approximately $334 million in trade sales revenue by the end of the quarter ending December 31, 2024.
Related Articles
US Stock Market Move | Nokia Oyj Sponsored ADR (NOK.US) rises 2% and establishes a new artificial intelligence department.
US Stock Market Move | Most new energy vehicle stocks are on the rise, with Lucid Group (LCID.US) up more than 8%.
Meta's annual Connect conference will release AI smart glasses. Zuckerberg is betting big on the smart hardware track.
US Stock Market Move | Nokia Oyj Sponsored ADR (NOK.US) rises 2% and establishes a new artificial intelligence department.
US Stock Market Move | Most new energy vehicle stocks are on the rise, with Lucid Group (LCID.US) up more than 8%.
Meta's annual Connect conference will release AI smart glasses. Zuckerberg is betting big on the smart hardware track.
